Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03862157
Title Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

chronic myelomonocytic leukemia

myelofibrosis

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic neutrophilic leukemia

acute myeloid leukemia

essential thrombocythemia

chronic eosinophilic leukemia

myeloproliferative neoplasm

polycythemia vera

myeloid neoplasm

Therapies

Azacitidine + MLN4924 + Venetoclax

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
M D Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field